成人肝移植后发生持续性血小板减少的危险因素分析及其预防措施探讨  

Risk factors of persistent thrombocytopenia after adult liver transplantation and prophylactic measures

作　　者：程龙宇[1] 俞军[1] 张武[1] 余松峰[1] 谢尚奋[1] 周琳[1] 张珉[1] 汤洒潇[1] 章琳[1] 郑树森[1] 

机构地区：[1]浙江大学医学院附属第一医院肝胆胰外科卫生部多器官联合移植研究重点实验室浙江省器官移植重点研究实验室

出　　处：《浙江大学学报（医学版）》2014年第6期670-677,共8页Journal of Zhejiang University(Medical Sciences)

基　　金：卫生行业科研专项项目(201002015);国家高技术研究发展计划(863计划)(2012AA021002)

摘　　要：目的：分析肝移植术后持续性血小板减少的危险因素，探索减少该疾病发生的有效治疗手段。方法：回顾性分析在浙江大学医学院附属第一医院肝胆胰外科2009年1月—2012年6月期间接受肝移植手术并符合纳入标准的128例患者资料，对移植前脾脏体积、术前门静脉直径、术前胃左静脉直径、术前和术后血小板、术前和术后白细胞、术前总胆红素水平及终末期肝病模型评分等指标进行统计分析，筛选术后持续性血小板减少的独立危险因素。并且对在2012—2013年期间部分术前存在危险因素的患者行肝移植同期脾动脉缩窄术，分析其术后持续性血小板减少的发生率。结果：患者肝移植术前脾脏体积大于500 ml （ P＝0.012， OR＝2.789，95％可信区间：1.249～6.227）以及门静脉直径大于15 mm （ P ＝0.017， OR＝3.124，95％可信区间：1.230～7.933）为术后持续性血小板减少的独立危险因素。行肝移植同期脾动脉缩窄术的6例患者中仅1例（16.7％）在术后表现为持续性血小板减少，而对照组48例中32例（66.7％）术后存在持续性血小板减少，两者间差异有统计学意义（ P＜0.05）。结论：患者肝移植术前脾脏体积大于500 ml以及门静脉直径大于15 mm可以作为肝移植术后持续性血小板减少的独立危险因素。肝移植手术同期行脾动脉缩窄术以控制脾脏体积作为肝移植术后持续性血小板减少的预防方法具有一定的临床效果。Objective： To investigate the risk factors associated with persistent thrombocytopenia after liver transplantation （ LT） , and to explore effective measures for prevention.Methods：One hundred and twenty-eight adult patients, who received liver transplantation in our hospital between January 2009 and June 2012 and met the inclusive criteria, were enrolled in the study.The clinical data were retrospectively analyzed, including pre-LT spleen volume, main portal vein size, coronary vein size, platelet and white blood cell levels, total bilirubin level and model of end stage liver disease score.The risk factors associated with persistent thrombocytopenia after LT were evaluated by logistic regression analysis. The effect of simultaneous splenic artery coarctation for high risk patients was evaluated withχ2 test.Results：Logistic regression analysis showed that per-LT spleen volume larger than 500 ml （ P =0.012, OR=2.789, 95%CI： 1.249 -6.227 ） and portal vein size beyond 15 mm （ P =0.017, OR =3.124, 95%CI： 1.230 -7.933 ） were independent risk factors for persistent thrombocytopenia after LT.The incidence rate of persistent thrombocytopenia after LT in patients with or without simultaneous splenic artery coarctation were 16.7%（1/6） and 66.7% （32/48）, respectively（P〈0.05）.Conclusion： Spleen volume larger than 500 ml and portal vein size beyond 15 mm are risk factors for persistent thrombocytopenia after LT.Simultaneous splenic artery coarctation may reduce the occurrence of persistent thrombocytopenia after LT.

关 键 词：肝移植 手术后期间 血小板减少/并发症 危险因素 体积描记术 脾/放射摄影术 脾动脉缩窄术/方法 回顾性研究 

分 类 号：R657.3[医药卫生—外科学]